United States · FDA National Drug Code directory
Montelukast Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-574_035c2d56-5707-4d1e-96b8-7c9c2e848bb6
- Product NDC
- 65862-574
- Form
- TABLET, FILM COATED
- Composition / generic term
- Montelukast Sodium
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120803
- Source listing expiry
- 20261231
Source-listed ingredients
- MONTELUKAST SODIUM — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (65862-574-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 65862-574-10
- 10000 TABLET, FILM COATED in 1 BOTTLE (65862-574-19) · 65862-574-19
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-574-30) · 65862-574-30
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-574-90) · 65862-574-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →